Important Characteristics




Simple & cost effective


Easy to manufacture

The proprietary lipids used in the products are made by standard & straightforward lipid synthesis techniques.

The GMP process has been validated and several GMP batches produced.


The cationic lipids are very well tolerated and are hydrolyzed into fatty acids and excreted.

This breakdown process contributes to the high safety profile of the platform.

The nanoparticles are made by standard and pre-existing liposome manufacturing techniques.

The company’s formulations eliminate the need for antigen encapsulation further simplifying the manufacturing process.

  • About Us

    PDS Biotechnology Corporation logo image

    PDS Biotechnology is a clinical stage biopharmaceutical company developing novel cancer immunotherapies and vaccines for infectious diseases.

  • Contact Us

    PDS Biotechnology Corporation
    Commercialization Center for Innovative Technologies (CCIT)

    675 US Highway one
    North Brunswick, NJ 08902

    Tel: 732-640-0145
    Fax: 732-640-0144